Novartis's Gilenya MS Pill Reviewed by EU, U.S. After 11 Deaths
San Francisco Chronicle
20 (Bloomberg) -- European and US regulators are reviewing Novartis AG's Gilenya pill for multiple sclerosis after reports of 11 deaths among patients who took the drug. The shares fell the most in almost three months. The reports raise concern that ...
See all stories on this topic »

EU agency issues guideline on biosimilar MS drugs
Reuters
Leading multiple sclerosis (MS) drugs containing interferon beta include Merck KGaA's Rebif and Biogen Idec's Avonex. Up to now, complex biotechnology medicines, which are given by injection, have been largely immune from generic competition, ...
See all stories on this topic »

Adeona commences multiple sclerosis drug trial
Pharmaceutical Business Review
Adeona Pharmaceuticals has begun the Phase II study of its Trimesta drug, used for the treatment of cognitive dysfunction in multiple sclerosis (MS). Trimesta is an oral estriol designed for treating relapsing-remitting MS and for cognitive dysfunction ...
See all stories on this topic »

National MS Society chapters join forces to create Greater Carolinas Chapter
Mountain Xpress
By Caitlin Byrd on 01/19/2012 03:08 PM In a realignment of chapter territories, the Mid-Atlantic and Eastern North Carolina Chapters of the National MS Society have joined together to form the Greater Carolinas Chapter. The new chapter serves a total ...
See all stories on this topic »

But clearly a man with terminal MS, who is blind and has dementia would not be ...
The Scottish Sun
By STUART MacDONALD THE wife of a dying multiple sclerosis sufferer blasted benefits bosses last night after they suggested he get a JOB. Elizabeth McGowan's hubby Stevie, 51, is registered blind, bed-ridden and has severe dementia. ...
See all stories on this topic »

NextGen Sciences Launches its 82 Protein Cerebrospinal Fluid (CSF) CNS Disease ...
San Francisco Chronicle (press release)
The new assay simultaneously measures 82 human CSF proteins that are thought to have potential as biomarkers in CNS diseases, particularly Alzheimer's, Parkinson's, multiple sclerosis and ALS diseases. The launch of csfdiscovery82 demonstrates the ...
See all stories on this topic »

Novartis drug investigated after 11 deaths
Seattle Post Intelligencer
LONDON (AP) — A multiple sclerosis drug made by industry giant Novartis is under investigation after at least 11 patients taking the medicine died. The drug, Gilenya, was licensed last year in the European Union to treat patients with a severe type of ...
See all stories on this topic »

JoAnne Romanelli Joins New Life Chiropractic wellness
NewsLI
Their private family practice, New Life Chiropractic, is dedicated to relieving chronic conditions that severely disable people, including, but not limited to, patients with Multiple Sclerosis, Parkinson?s, Alzheimer?s, Autism Spectrum Disorders, ...
See all stories on this topic »

The Ex Factor
Wall Street Journal
According to ABC, Marianne Gingrich "said Newt moved for the divorce just months after she had been diagnosed with Multiple Sclerosis, with her then-husband present. 'He also was advised by the doctor when I was sitting there that I was not to be under ...
See all stories on this topic »